Fundraising FoxImlay Investments
FoundationAtlanta · Seed–Late Stage · 2 people tracked
Find your way into Imlay Investments
Investment thesis
The foundation invests in people and organizations with passion, principles, and leadership qualities dedicated to improving lives within their communities. Through strategic charitable giving, the foundation seeks to generate lasting positive impact that extends across multiple years.
Source: firm website, verified Jul 30, 2026.
What founders say
No founder feedback on Imlay Investments yet.
Team · 2 people
from the firm's websiteInvestments · 2 tracked
founders shown can be your intro pathOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- What stage does Imlay Investments invest at?
- Imlay Investments invests at the Seed, Late Stage stages.
- What sectors does Imlay Investments focus on?
- Imlay Investments focuses on Impact & Social Good.
- Where is Imlay Investments located?
- Imlay Investments is headquartered in Atlanta, US.
Images
Similar investors
Buckhill Capital LP is a San Francisco-based impact-focused private equity and venture capital firm (also operating a middle-market lending arm, Buckhill Credit) that backs companies building sustainable systems and healthy communities.
CareQuest Innovation Partners drives innovation in oral and integrated health through impact investing, innovation programs, and corporate partnerships aimed at improving accessibility, equity, and the integration of oral health with overall health.
Emerald Technology Ventures is a venture capital investor focused on complex, cutting-edge technologies, supporting entrepreneurs at the frontier of scientific and industrial innovation.
Norrsken22 is a tech growth fund backing entrepreneurs building disruptive, scalable tech-enabled businesses across Africa, providing growth capital and strategic support while positioning them for international expansion.
Ysios Capital is a life sciences venture investor that finances innovative biotech companies developing novel therapies for high unmet medical needs, primarily across Europe and the United States.